Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Heart disease and stroke cost the Canadian economy an estimated $20.9 billion annually in direct healthcare costs and lost productivity
This is a suggested starting point, not a prescribed timeline
Because our approach targets underlying lifestyle and behavioral drivers, it can positively impact 200+ obesity-related chronic conditions, leading to better long-term health outcomes and reduced healthcare costs
Buse, MD, PhD, will discuss new insights from the VESPER program examining berobenatide, an ultra-long-acting glucagon-like peptide-1 (GLP-1) receptor agonist for weight management
US$ 28.36
US$ 23.50
US$ 21.99
US$ 20.25
US$ 25.29
US$ 25.38
US$ 28.24
US$ 22.25
US$ 26.34
US$ 21.29
US$ 24.91
